Timberland Bancorp Fiscal Year Net Income Increases 40% to $14.17 Million
Nov 01, 2017 13:02 pm UTC| Business
Fiscal Year Earnings Per Share Increases 34% to $1.92Fiscal Year Return on Equity Increases to 13.65%Fiscal Year Return on Assets Increases to 1.53% HOQUIAM, Wash., Nov. 01, 2017 -- Timberland Bancorp, Inc....
Nov 01, 2017 13:02 pm UTC| Business
CAMBRIDGE, Mass. and BEIJING, China, Nov. 01, 2017 -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and...
Natural Health Trends Reports Third Quarter 2017 Financial Results
Nov 01, 2017 13:02 pm UTC| Business
Positive sales momentum in emerging international marketsMaintained strong gross profit and operating income margins Announced market entry into MalaysiaIncreased quarterly dividend 9% to $0.12 per share Declared special...
Nov 01, 2017 13:02 pm UTC| Business
BERKELEY HEIGHTS, N.J., Nov. 01, 2017 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (Cyclacel or the Company), a clinical-stage biopharmaceutical company using cell cycle, transcriptional regulation and...
Determine, Inc. Shares Industry-Leading Supplier Relationship Expertise in Paystream Webinar
Nov 01, 2017 13:02 pm UTC| Business
CARMEL, Ind., Nov. 01, 2017 -- Determine, Inc. (NASDAQ:DTRM), the pioneering leader in global Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM) Cloud Platform solutions, will present a live webinar with...
Stemline Announces Four SL-401 Presentations at Upcoming ASH Meeting
Nov 01, 2017 13:02 pm UTC| Business
NEW YORK, Nov. 01, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that SL-401, a novel...
Fate Therapeutics Announces Six Presentations at the 2017 ASH Annual Meeting
Nov 01, 2017 13:02 pm UTC| Business
Oral Presentation Unveiling Generation of CD8αβ+ T Cells from Engineered Pluripotent Cell Line for Off-the-Shelf CAR T-Cell Cancer Immunotherapy Oral Presentation Highlighting GMP Production of iPSC-derived NK Cell...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
The Mattei Plan: why Giorgia Meloni is looking to Africa
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight